U.S. Medicinal Chemistry for Drug Discovery Market to 2032
Overview
The U.S. Medicinal Chemistry for Drug Discovery Market is expected to reach a 9.54 USD Billion by 2032 and is projected to grow at a CAGR of 23.50% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.25
Forecast, 2032 (USD Billion)
9.54
CAGR, 2024 - 2032
23.50%
Report Coverage
U.S.
U.S. Medicinal Chemistry for Drug Discovery Market 2018-2032 USD Billion
U.S. Medicinal Chemistry for Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.25 USD Billion
- Projected Market Size (2032): 9.54 USD Billion
- CAGR (2025-2032): 23.50%
Key Findings of U.S. Medicinal Chemistry for Drug Discovery Market
- The U.S. Medicinal Chemistry for Drug Discovery Market was valued at 9.54 USD Billion in 2024.
- The U.S. Medicinal Chemistry for Drug Discovery Market is likely to grow at a CAGR of 23.50% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecules in Drug Type Segment accounted for the largest share of the market with a revenue of 2.07 USD Billion
- The fastest growing segment Target Selection in Process Segment grew Fastest with a CAGR of 30.95% during the forecast period from 2024 to 2032.
U.S. Medicinal Chemistry for Drug Discovery Market Scope
U.S. Medicinal Chemistry for Drug Discovery Market Segmentation & Scope
Process
- Candidate Validation
- Lead Optimization
- Hit-To-Lead Identification
- Target Validation
- Target Selection
Design
- Others
- Natural Products
- Chemogenomics
- Diversity Oriented Synthesis
- Structure Based Drug Design
- Fragment-Based Variation
End User
- Others
- Academic And Research Institutes
- Pharmaceutical And Biotechnology Companies
- Contract Research Organization
Therapeutic Area
- Digestive System Diseases
- Cardiovascular Diseases
- Others
- Infectious And Immune System Diseases
- Neurology
- Oncology
Drug Type
- Biologics
- Small Molecules
U.S. Medicinal Chemistry for Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.25 USD Billion |
| Market Value in 2032 | 9.54 USD Billion |
| CAGR (2025-2032) | 23.50% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Process, Design, End User, Therapeutic Area, Drug Type |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 3.25 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 3,250.15 USD Million in 2024.
Segments and Scope
-
U.S. Medicinal Chemistry for Drug Discovery Market to 2032, By Process
- Target Selection is the largest segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a revenue of 1.06 USD Billion in the year 2024.
- Target Selection is the Fastest growing segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a Growth rate of 30.95 % in forecast period 2025-2032.
-
U.S. Medicinal Chemistry for Drug Discovery Market to 2032, By Design
- Fragment-Based Variation is the largest segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a revenue of 1.18 USD Billion in the year 2024.
- Fragment-Based Variation is the Fastest growing segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a Growth rate of 29.44 % in forecast period 2025-2032.
-
U.S. Medicinal Chemistry for Drug Discovery Market to 2032, By End User
- Contract Research Organization is the largest segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a revenue of 1.51 USD Billion in the year 2024.
- Contract Research Organization is the Fastest growing segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a Growth rate of 25.42 % in forecast period 2025-2032.
-
U.S. Medicinal Chemistry for Drug Discovery Market to 2032, By Therapeutic Area
- Oncology is the largest segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a revenue of 1.12 USD Billion in the year 2024.
- Infectious And Immune System Diseases is the Fastest growing segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a Growth rate of 27.82 % in forecast period 2025-2032.
-
U.S. Medicinal Chemistry for Drug Discovery Market to 2032, By Drug Type
- Small Molecules is the largest segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a revenue of 2.07 USD Billion in the year 2024.
- Biologics is the Fastest growing segment in U.S. Medicinal Chemistry for Drug Discovery Market to 2032 with a Growth rate of 22.11 % in forecast period 2025-2032.
U.S. Medicinal Chemistry for Drug Discovery Market Company Share Analysis
| Company Name |
|
||
| Labcorp Drug Development | |||
| Thermo Fisher Scientific Inc. | |||
| WuXi AppTec | |||
| Piramal Pharma Solutions | |||
| Charles River Laboratories | |||
U.S. Medicinal Chemistry for Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Medicinal Chemistry for Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Medicinal Chemistry for Drug Discovery Market is segmented based on Segmentation Process, Design, End User, Therapeutic Area, Drug Type.
U.S. Medicinal Chemistry for Drug Discovery Market was valued at USD 3.25(Revenue in USD Billion) in 2020.
U.S. Medicinal Chemistry for Drug Discovery Market is projected to grow at a CAGR of 23.50% during the forecast period of 2024 to 2032.
The Small Molecules segment is expected to dominate the U.S. Medicinal Chemistry for Drug Discovery Market, holding a largest market share of 2.07 USD Billion in 2024
U.S. Medicinal Chemistry for Drug Discovery Market Scope
U.S. Medicinal Chemistry for Drug Discovery Market Segmentation & Scope
Process
- Candidate Validation
- Lead Optimization
- Hit-To-Lead Identification
- Target Validation
- Target Selection
Design
- Others
- Natural Products
- Chemogenomics
- Diversity Oriented Synthesis
- Structure Based Drug Design
- Fragment-Based Variation
End User
- Others
- Academic And Research Institutes
- Pharmaceutical And Biotechnology Companies
- Contract Research Organization
Therapeutic Area
- Digestive System Diseases
- Cardiovascular Diseases
- Others
- Infectious And Immune System Diseases
- Neurology
- Oncology
Drug Type
- Biologics
- Small Molecules
Frequently Asked Questions
The U.S. Medicinal Chemistry for Drug Discovery Market is segmented based on Segmentation Process, Design, End User, Therapeutic Area, Drug Type.
U.S. Medicinal Chemistry for Drug Discovery Market was valued at USD 3.25(Revenue in USD Billion) in 2020.
U.S. Medicinal Chemistry for Drug Discovery Market is projected to grow at a CAGR of 23.50% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Medicinal Chemistry for Drug Discovery Market for final year is USD 9.54 (USD Billion).
U.S. Medicinal Chemistry for Drug Discovery Market Company Profiling
Frequently Asked Questions
The U.S. Medicinal Chemistry for Drug Discovery Market is segmented based on Segmentation Process, Design, End User, Therapeutic Area, Drug Type.
U.S. Medicinal Chemistry for Drug Discovery Market was valued at USD 3.25(Revenue in USD Billion) in 2020.
U.S. Medicinal Chemistry for Drug Discovery Market is projected to grow at a CAGR of 23.50% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Medicinal Chemistry for Drug Discovery Market for final year is USD 9.54 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.